Publications

Department of Medicine faculty members published more than 3,600 peer-reviewed articles in 2024.

Arthritis and rheumatism

Accelerated nodulosis and vasculitis following etanercept therapy for rheumatoid arthritis.

2002

Authors: Cunnane G, Warnock M, Fye KH, Daikh DI

Clinical cancer research : an official journal of the American Association for Cancer Research

A phase I trial of the novel proteasome inhibitor PS341 in advanced solid tumor malignancies.

2002

Authors: Aghajanian C, Soignet S, Dizon DS, Pien CS, Adams J, Elliott PJ, Sabbatini P, Miller V, Hensley ML, Pezzulli S, Canales C, Daud A, Spriggs DR

Journal of pharmacokinetics and pharmacodynamics

Modeling nicotine arterial-venous differences to predict arterial concentrations and input based on venous measurements: application to smokeless tobacco and nicotine gum.

2002

Authors: Pitsiu M, Gries JM, Benowitz N, Gourlay SG, Verotta D

Journal of molecular and cellular cardiology

Alpha(1)-adrenoceptor subtypes mediate negative inotropy in myocardium from alpha(1A/C)-knockout and wild type mice.

2002

Authors: McCloskey DT, Rokosh DG, O'Connell TD, Keung EC, Simpson PC, Baker AJ

Kidney international

Modest serum creatinine elevation affects adverse outcome after general surgery.

2002

Authors: O'Brien MM, Gonzales R, Shroyer AL, Grunwald GK, Daley J, Henderson WG, Khuri SF, Anderson RJ

Antimicrobial agents and chemotherapy

Effects of gender, AIDS, and acetylator status on intrapulmonary concentrations of isoniazid.

2002

Authors: Conte JE, Golden JA, McQuitty M, Kipps J, Duncan S, McKenna E, Zurlinden E

Journal of virology

Selective loss of innate CD4(+) V alpha 24 natural killer T cells in human immunodeficiency virus infection.

2002

Authors: Sandberg JK, Fast NM, Palacios EH, Fennelly G, Dobroszycki J, Palumbo P, Wiznia A, Grant RM, Bhardwaj N, Rosenberg MG, Nixon DF

Seminars in respiratory and critical care medicine

Airway remodeling in asthma.

2002

Authors: Woodruff PG, Fahy JV

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

American Society of Clinical Oncology technology assessment of pharmacologic interventions for breast cancer risk reduction including tamoxifen, raloxifene, and aromatase inhibition.

2002

Authors: Chlebowski RT, Col N, Winer EP, Collyar DE, Cummings SR, Vogel VG, Burstein HJ, Eisen A, Lipkus I, Pfister DG

Cancer cell

Multiple BCR-ABL kinase domain mutations confer polyclonal resistance to the tyrosine kinase inhibitor imatinib (STI571) in chronic phase and blast crisis chronic myeloid leukemia.

2002

Authors: Shah NP, Nicoll JM, Nagar B, Gorre ME, Paquette RL, Kuriyan J, Sawyers CL